Last update 19 Apr 2025

Semaglutide(Hainan Zhonghe)

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
司美格鲁肽注射液
Target
GLP-1R
Action
agonists
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
ObesityDiabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Hainan Zhonghe Pharmaceutical Co., Ltd.Hainan Zhonghe Pharmaceutical Co., Ltd.
Active Organization
Hainan Zhonghe Pharmaceutical Co., Ltd.Hainan Zhonghe Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Semaglutide(Hainan Zhonghe)
CTR20244841
/ RecruitingPhase 3
在肥胖受试者中比较司美格鲁肽注射液和Wegovy®对体重管理有效性和安全性的多中心、随机、开放、平行对照III期临床研究
[Translation] A multicenter, randomized, open-label, parallel-controlled Phase III clinical study comparing the efficacy and safety of semaglutide injection and Wegovy® in weight management in obese subjects
CTR20244146
/ Not yet recruitingPhase 3
评价司美格鲁肽注射液在成人非糖尿病肥胖患者中作为生活方式干预辅助治疗的Ⅲ期临床试验
[Translation] Phase III clinical trial evaluating semaglutide injection as an adjunct to lifestyle intervention in non-diabetic obese adults
100 Clinical Results associated with Semaglutide(Hainan Zhonghe)
Login to view more data
100 Translational Medicine associated with Semaglutide(Hainan Zhonghe)
Login to view more data
100 Patents (Medical) associated with Semaglutide(Hainan Zhonghe)
Login to view more data
100 Deals associated with Semaglutide(Hainan Zhonghe)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityIND Approval
China
Hainan Zhonghe Pharmaceutical Co., Ltd.Hainan Zhonghe Pharmaceutical Co., Ltd.
11 Apr 2025
Diabetes Mellitus, Type 2IND Approval
China
Hainan Zhonghe Pharmaceutical Co., Ltd.Hainan Zhonghe Pharmaceutical Co., Ltd.
20 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free